Some cancers, such as acute lymphoblastic leukemia (ALL), depend on asparagine availability to maintain cell survival, which is exploited clinically with the use of the bacterially derived enzyme asparaginase that depletes asparagine [1,2,3,4]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.